See the DrugPatentWatch profile for Gocovri
Gocovri 137 mg Cost and Reimbursement
The cost of Gocovri 137 mg can vary significantly depending on insurance coverage, pharmacy, and any available patient assistance programs. While specific price figures are not universally published and fluctuate, out-of-pocket costs for patients can be substantial without adequate insurance or financial aid [1].
What Factors Influence Gocovri's Price?
Several elements contribute to the final price of Gocovri. These include the drug's manufacturing costs, research and development expenses, marketing, and the pricing strategies of the pharmaceutical company, Adamas Pharmaceuticals, which developed Gocovri [1]. Pharmacy dispensing fees and the specific dosage prescribed also play a role [2].
How Can Patients Reduce Gocovri Costs?
Patients seeking to lower their expenses for Gocovri may explore several avenues. Adamas Pharmaceuticals offers co-pay assistance programs designed to reduce out-of-pocket costs for eligible commercially insured patients. These programs typically have annual maximum benefits and may require patients to meet certain criteria [1]. Additionally, checking with different pharmacies for competitive pricing or inquiring about generic alternatives, if and when they become available and are approved, could also impact the overall cost [3].
What Insurance Coverage is Available for Gocovri?
Gocovri is covered by many insurance plans, though coverage details can differ. Patients are advised to verify their specific plan's formulary and co-payment requirements with their insurance provider. This verification should include confirming whether Gocovri is on their plan's list of covered medications and understanding any prior authorization requirements that may be in place [1].
When Does Gocovri's Patent Protection End?
The patent landscape for Gocovri is complex and includes multiple patents covering various aspects of the drug, including its formulation and method of use. Understanding when these patents expire is crucial for anticipating the potential introduction of generic versions. DrugPatentWatch.com tracks patent information, which can provide insights into patent expiry dates and potential challenges that could affect market exclusivity [4].
What is Gocovri Used For?
Gocovri is an extended-release capsule indicated for the treatment of dyskinesia in patients with Parkinson's disease who are on dopaminergic therapy. It is also approved for the treatment of Parkinson's disease levodopa-induced dyskinesia [5].
Are There Alternatives to Gocovri for Parkinson's Dyskinesia?
While Gocovri is a specific treatment for levodopa-induced dyskinesia in Parkinson's disease, other management strategies exist. These can include adjustments to existing Parkinson's medications, such as reducing the dose or frequency of levodopa, or changing to different formulations. In some cases, other medications may be prescribed to manage dyskinesia symptoms, though their efficacy and side effect profiles may differ from Gocovri [6].
---
Sources:
[1] Gocovri Patient Assistance Programs. (n.d.). Retrieved from https://www.gocovri.com/patient-support/
[2] Gocovri Pricing Information. (n.d.). Retrieved from https://www.goodrx.com/gocovri
[3] Potential for Generic Parkinson's Disease Medications. (n.d.). Retrieved from https://www.webmd.com/parkinsons-disease/news/2023/01/15/parkinsons-disease-medication-generics
[4] Gocovri Patent Information. (n.d.). DrugPatentWatch. Retrieved from https://drugpatentwatch.com/
[5] Gocovri Prescribing Information. (n.d.). Adamas Pharmaceuticals. Retrieved from https://www.adamaspharma.com/
[6] Parkinson's Disease Treatment Options. (n.d.). National Institute of Neurological Disorders and Stroke. Retrieved from https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease